82 filings
Page 4 of 5
8-K
8om05t8
17 Jul 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
6en19c
13 Jul 20
Iterum Therapeutics Informs Shareholders of Record Date for Planned Rights Offering
4:30pm
8-K
snfcupi p936
30 Jun 20
Iterum Therapeutics Announces $5 Million Registered Direct Offering PricedAt-the-Market under Nasdaq Rules
9:37pm
8-K
lfqlpq02 od
29 Jun 20
Sulopenem demonstrates superiority in treatment of patients with quinolone resistant pathogens
7:45am
8-K
ddg5lgh
15 Jun 20
Material Modifications to Rights of Security Holders
4:45pm
8-K
itgx udjk
4 Jun 20
Iterum Therapeutics Announces $5 Million Registered Direct Offering PricedAt-the-Market under Nasdaq Rules
5:28pm
8-K
57dkv0af
2 Jun 20
Iterum Therapeutics Announces Topline Results for a Phase 3 Clinical Trial of Oral and IV
9:57pm
8-K
h9lw8k3di3fop1y bolq
15 May 20
Other Events
4:04pm
8-K
l79z4c
14 May 20
Iterum Therapeutics Reports First Quarter 2020 Financial Results
7:00am
8-K
87zfd470k1mw2xjk
12 Mar 20
Iterum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
7:00am
8-K
q24tg 9w4f41crcuw
6 Mar 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:30pm
8-K
gjsmban3bxk1a9x
14 Feb 20
Departure of Directors or Certain Officers
12:00am
8-K
6412l0aetw g3sc
17 Jan 20
Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors
6:23am
8-K
7hcrgv q6xoawf
12 Nov 19
Iterum Therapeutics Reports Third Quarter 2019 Financial Results and Highlights
4:45pm
8-K
0iz2dg7
14 Aug 19
Iterum Therapeutics Reports Second Quarter 2019 Financial Results
12:00am
8-K
ry6 3hjyil
17 Jun 19
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
357zguuz
14 May 19
Iterum Therapeutics Reports First Quarter 2019 Financial Results
7:15am
8-K
a442u
25 Mar 19
Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
7:16am
8-K
olmcwilad5 zzi5f
14 Nov 18
Iterum Reports Third Quarter 2018 Financial Results and Recent Highlights
7:31am
8-K
639f i6iifu
19 Oct 18
Regulation FD Disclosure
5:25pm